Clinical Trial Update: Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating antiviral therapy to prevent de novo hepatitis C infection after liver or kidney transplant; study completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Transplantation Disease Transmission

Snippet

Sponsor: University of California, San Francisco | Conditions: Hepatitis C, Transplantation Disease Transmission | Phase 4 | Status: COMPLETED | Results posted: 2021-03-03